Literature DB >> 6419257

Functional tolerance to lorazepam in the rat.

R G Lister, S E File, D J Greenblatt.   

Abstract

The nature of the tolerance that develops to the sedative action of lorazepam was investigated using a hole-board apparatus. Rats treated with lorazepam (0.125, 0.25 and 0.50 mg/kg) once daily for 3 days showed similar degrees of tolerance to the effects of a test dose of 0.25 mg/kg lorazepam. Tolerance was also observed in animals treated once every 2 days with lorazepam (0.50 mg/kg). Measurement of the plasma and brain concentrations of lorazepam immediately after the behavioural test showed that this tolerance was functional and not dispositional. In contrast, the behavioural effects of lorazepam were not reduced as a result of 3 days of treatment with a sedative dose of sodium pentobarbitone (20 mg/kg), although this led to lower brain concentrations of lorazepam at the time of testing.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6419257     DOI: 10.1007/BF00427565

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  17 in total

1.  Analysis of lorazepam and its glucuronide metabolite by electron-capture gas--liquid chromatography. Use in pharmacokinetic studies of lorazepam.

Authors:  D J Greenblatt; K Franke; R I Shader
Journal:  J Chromatogr       Date:  1978-09-01

Review 2.  Tolerance to, and dependence on, some non-opiate psychotropic drugs.

Authors:  H Kalant; A E LeBlanc; R J Gibbins
Journal:  Pharmacol Rev       Date:  1971-09       Impact factor: 25.468

3.  Tolerance development with chlordiazepoxide in relation to the plasma levels of the parent compound and its main metabolites in mice.

Authors:  J D Christensen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1973

4.  Increase of "antianxiety" activity and tolerance of behavioral depression during chronic administration of oxazepam.

Authors:  D L Margules; L Stein
Journal:  Psychopharmacologia       Date:  1968

5.  Profile of acute tolerance to three sedative anxiolytics.

Authors:  E H Ellinwood; M Linnoila; M E Easler; D W Molter
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

6.  The behavioural effects of lorazepam are poorly related to its concentration in the brain.

Authors:  R G Lister; S E File; D J Greenblatt
Journal:  Life Sci       Date:  1983-04-25       Impact factor: 5.037

7.  Rapid development of tolerance to the sedative effects of lorazepam and triazolam in rats.

Authors:  S E File
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

8.  Medical therapies for mood disorders alter the blood-brain barrier.

Authors:  S H Preskorn; G H Irwin; S Simpson; D Friesen; J Rinne; G Jerkovich
Journal:  Science       Date:  1981-07-24       Impact factor: 47.728

9.  Methods for the determination of lorazepam and chlordiazepoxide and metabolites in brain tissue. A comparison with plasma concentrations in the rat.

Authors:  R G Lister; D R Abernethy; D J Greenblatt; S E File
Journal:  J Chromatogr       Date:  1983-10-14

10.  Chronic clonazepam administration induces benzodiazepine receptor subsensitivity.

Authors:  J N Crawley; P J Marangos; J Stivers; F K Goodwin
Journal:  Neuropharmacology       Date:  1982-01       Impact factor: 5.250

View more
  2 in total

1.  Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models.

Authors:  M Bourin; M Hascoet; B Mansouri; M C Colombel; J Bradwejn
Journal:  J Psychiatry Neurosci       Date:  1992-06       Impact factor: 6.186

2.  Chronic benzodiazepine administration. XII. Anticonvulsant cross-tolerance but distinct neurochemical effects of alprazolam and lorazepam.

Authors:  J J Byrnes; L G Miller; D J Greenblatt; R I Shader
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.